기업 프로필 · Healthcare

Quest Diagnostics Incorporated

DGX · 미국
거래소
미국
국가 / 지역
USA
상장일
1996년 12월 17일
직원 수
57,000
현재가
$195
실시간 · 2026년 6월 18일
적정 매수가
≤ $165
안전마진 진입가
베일리 성장 점수
41/100
다소 약함
내재가치 · 3단계 구간 현재가 $195 실시간 · 적정 내재가치 구간 내

종합 밸류에이션 구간 · 보수적 $135–$155 / 적정 $180–$205 / 낙관적 $230–$255. $195 기준, 적정 내재가치 구간 내.

보고서 발행 시 $196.2(2026년 5월 29일)

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

시가총액US$218.91억
매출 (TTM)US$112.78억
EBITDAUS$22.26억
순이익률9.08%
ROE14.54%
PER (TTM)21.85
선행 PER18.42
PEG1.52
EPSUS$9.05
배당수익률1.62%
52주 범위US$162.47 – US$212.58
애널리스트 목표주가US$223.44
애널리스트 평가3.9 / 5

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

연혁

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

업계 내 위치

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.